BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4403918)

  • 1. Arterial blood pressure decrease following adrenergic -receptor stimulation in the central nervous system.
    Kroneberg G; Heise A
    Jpn J Pharmacol; 1972; 22():Suppl22:14. PubMed ID: 4403918
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous alpha-adrenergic receptors and the mode of action of alpha-methyldopa.
    Heise A; Kroneberg G
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(3):285-300. PubMed ID: 4147968
    [No Abstract]   [Full Text] [Related]  

  • 3. -Sympathetic receptor stimulation in the brain and hypotensive activity of -methyldopa.
    Heise A; Kroneberg G
    Eur J Pharmacol; 1972 Feb; 17(2):315-7. PubMed ID: 4402101
    [No Abstract]   [Full Text] [Related]  

  • 4. On the function of central catecholamine neurons--their role in cardiovascular and arousal mechanisms.
    Bolme P; Fuxe K; Lidbrink P
    Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):657-97. PubMed ID: 4404753
    [No Abstract]   [Full Text] [Related]  

  • 5. [The central component of the blood pressure lowering effect of alpha-methyldopa in cats].
    Henning M; van Zwieten PA
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):140-1. PubMed ID: 4239179
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pressor and depressor action of BAY 1470 (2-(2,6-Xylidino)-5,6-dihydro-4H-1,3-thiazinehydrochloride) as a consequence of its -receptor-stimulating properties].
    Heise A; Kroneberg G; Schlossmann K
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(3):348-60. PubMed ID: 4402233
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of centrally mediated hypotensive action of methyldopa and DOPA in cats.
    Torchiana ML; Lotti VJ; Clark CM; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):103-13. PubMed ID: 4148405
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypothermic effect of alpha-sympathomimetic agents and their antagonism by adrenergic and cholinergic blocking drugs.
    Tsoucaris-Kupfer D; Schmitt H
    Neuropharmacology; 1972 Sep; 11(5):625-35. PubMed ID: 4151249
    [No Abstract]   [Full Text] [Related]  

  • 9. Central hypotensive action of alpha-methyldopa: an iontophoretic study in the cat.
    Sharma JN; Sandrew BB; Wang SC
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):92-9. PubMed ID: 526073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of L-dopa-induced postural hypotension in the cat.
    Dhasmana KM; Spilker BA
    Br J Pharmacol; 1973 Mar; 47(3):437-51. PubMed ID: 4147189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of the conversion of alpha-methyldopa to an active symphathomimetic by 3-hydroxy-4-bromobenzyloxyamine (NSD 1055) and 3-hydroxybenzyloxyamine (NSD 1024).
    Weber LJ
    Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):124-7. PubMed ID: 6056583
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for increased vagal tone and enhancement of baroreceptor reflex activity after xylazine (2-(2,6-dimethylphenylamino)-4-H-5,6-dihydro-1,3-thiazine) in anesthestized dogs.
    Antonaccio MJ; Robson RD; Kerwin L
    Eur J Pharmacol; 1973 Sep; 23(3):311-6. PubMed ID: 4746747
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the effects of xylazine and acetylpromazine maleate in the horse.
    Kerr DD; Jones EW; Holbert D; Huggins K
    Am J Vet Res; 1972 Apr; 33(4):777-84. PubMed ID: 5017870
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for a central sympathoexcitatory action of alpha-2 adrenergic antagonists.
    McCall RB; Schuette MR; Humphrey SJ; Lahti RA; Barsuhn C
    J Pharmacol Exp Ther; 1983 Mar; 224(3):501-7. PubMed ID: 6131117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sedative and other effects of xylazine given intravenously to horses.
    Kerr DD; Jones EW; Huggins K; Edwards WC
    Am J Vet Res; 1972 Mar; 33(3):525-32. PubMed ID: 5014460
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psychopharmalogical study of a central alpha-sympathomimetic agent, xylazine analgesic and tranquillizer in veterinary medicine].
    Simon P; Chermat R; Puech AJ; Goujet MA; Boissier JR
    Therapie; 1973; 28(4):735-51. PubMed ID: 4152448
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of alpha-sympathomimetic agents in the central nervous system. Study of the central effects of adrenergic drugs by injection into the vertebral artery].
    Van Zwieten PA
    Therapie; 1972; 27(4):565-75. PubMed ID: 4404301
    [No Abstract]   [Full Text] [Related]  

  • 18. [Peripheral and central circulatory effect of the alpha-sympathomimetic 2-(2,6-xylidino)-5,6-dihydro-4H-1,3-thiazine-HCl (BAY 1470)].
    Heise A; Kroneberg G
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):350-1. PubMed ID: 4397501
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypotensive effects of large doses of ephedrine on blood pressure in cats].
    LangwiƄski R; Jagiello E
    Acta Physiol Pol; 1969; 20(5):819-28. PubMed ID: 4393770
    [No Abstract]   [Full Text] [Related]  

  • 20. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.